RECAP
ESMO 2026 — 117 trials, 1,732 results slides and physician reactions, all in one place
See ESMO 2026 results →
Trials
KOLs
Conferences
Insights
Book a Demo
All trial profiles
→
Results, slides and physician reactions for 240+ oncology trials
ESMO 2026 trial results
117 trials with KOL reactions
Cross-trial comparisons
Perioperative IO in resectable NSCLC
Metastatic TNBC FDA approvals
KOL Hub
→
Rankings, KOL profiles and KOL × trial matrices in one place
Top oncology KOLs 2026
Top lung cancer KOLs
Top breast cancer KOLs
Top GI cancer KOLs
Top GU cancer KOLs
Top multiple myeloma KOLs
KOL × trial matrices
Lung cancer KOL × trial matrix
Breast cancer KOL × trial matrix
GI cancer KOL × trial matrix
GU cancer KOL × trial matrix
Myeloma KOL × trial matrix
Conference influencer networks
All conferences
→
KOL voices, slides and trial buzz from every congress we cover
Latest coverage
ESMO 2026
Results, slides and oncologist reactions
ESMO 2026 slide library
IMS 2026
WCLC 2026 slide library
Daily Digest
What's hot in hematology/oncology today
Weekly Insights
KOL takeaways by tumor type
AI in Oncology
What physicians are saying about AI
Insights Blog
KOL
Pulse
3082-CL-0101 (Setidegrasib) — Social Network
Tweets
12
KOLs
8
Nodes
57
Links
64
US Physicians
5
View
All Nodes
57
KOLs
8
US Influence
All US Physicians
5
US Retweeters
5
Other
Media
6
Link Type
Mentions
11
Retweets
53
No US physicians found in this trial's network
KOL (Influencer)
US Physician
Retweeter
Mentioned
Media